Blaine Davis - Nov 28, 2022 Form 4 Insider Report for SELECTA BIOSCIENCES INC (SELB)

Role
Chief Financial Officer
Signature
Matthew Bartholomae, Attorney-in-Fact for Blaine Davis
Stock symbol
SELB
Transactions as of
Nov 28, 2022
Transactions value $
$0
Form type
4
Date filed
11/30/2022, 03:40 PM
Previous filing
Jul 19, 2022
Next filing
Nov 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SELB Employee Stock Option (right to buy) Award $0 +1.25M $0.00 1.25M Nov 28, 2022 Common Stock 1.25M $1.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 25% on November 28, 2023. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.